Biomembranse of hemicellulose dressing versus collagenase in the treatment of chronic venous ulcers: randomized clinical trial, open and controlled study

Faculdade de Medicina de Botucatu - Unesp0 个研究点开始时间: 2016年9月19日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Sign the consent form; ge above 18 years; of both sexes; Venous chronic disease with venous chronic ulcer evidenced by one or more of the following signs: Hyperpigmentation of the distal third of the lower limb; stasis eczema; lipodermatosclerosis; varicose veins; One or more ulcers whose minimum evolution time is 6 weeks; present ulcer whose largest size is linear up to 20cm; Ulcers do not occur throughout the circumference of the member
•Do not use venotonics drugs; pentoxifylline and fibrinolytic drugs in the last two weeks before the study

•Having other etiologies ulcers (peripheral arterial disease, causes hematologic, neoplastic, infectious, etc.); Ulcer whose largest linear size is more than 20cm; Ulcers occurring throughout the limb circumference;
•Infected ulcer, or when combined with erysipelas, cellulitis or lymphangitis;
•Ulcers with critical colonization, or large amounts of exudate and/or foul odor and/or color of the green bed; Necrosis presence in ulcer bed; Venous ulcers associated with peripheral arterial disease that is characterized when the ankle-brachial systolic index (ABI) is less than 0.9 and / or absence of distal pulses, mainly tibioso; History of hypersensitivity to the proposed treatments

发起方

Faculdade de Medicina de Botucatu - Unesp